0001199719-22-000065.txt : 20220822 0001199719-22-000065.hdr.sgml : 20220822 20220822132156 ACCESSION NUMBER: 0001199719-22-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220819 FILED AS OF DATE: 20220822 DATE AS OF CHANGE: 20220822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUNKEL JOHN F JR CENTRAL INDEX KEY: 0001206990 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19807 FILM NUMBER: 221183084 MAIL ADDRESS: STREET 1: C/O INTUITIVE SURGICAL, INC. STREET 2: 1266 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNOPSYS INC CENTRAL INDEX KEY: 0000883241 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 561546236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 690 E MIDDLEFIELD RD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6505845000 MAIL ADDRESS: STREET 1: 690 E MIDDLEFIELD RD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-08-19 0 0000883241 SYNOPSYS INC SNPS 0001206990 RUNKEL JOHN F JR 690 EAST MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 0 1 0 0 GC & Corporate Secretary Common Stock 2022-08-19 4 M 0 569 234.17 A 23192 D Common Stock 2022-08-19 4 S 0 569 365.488 D 22623 D Common Stock 2022-08-19 4 M 0 1572 135.88 A 24195 D Common Stock 2022-08-19 4 S 0 1572 365.488 D 22623 D Common Stock 2022-08-19 4 M 0 1323 89.76 A 23946 D Common Stock 2022-08-19 4 S 0 1323 365.488 D 22623 D Non-Qualified Stock Option (right to buy) 89.76 2022-08-19 4 M 0 1323 0.0 D 2019-12-12 2025-12-12 Common Stock 1323 2646 D Non-Qualified Stock Option (right to buy) 135.88 2022-08-19 4 M 0 1572 0.0 D 2020-12-12 2026-12-12 Common Stock 1572 9432 D Non-Qualified Stock Option (right to buy) 234.17 2022-08-19 4 M 0 569 0.0 D 2021-12-10 2027-12-10 Common Stock 569 5695 D Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $361.89 to $368.85. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. By: POA pursuant Christina Escalante-Dutra For: John Frederick Runkel, Jr. 2022-08-22